Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
Jiří Masopust,1–4 Dita Protopopová,4 Martin Vališ,2,3 Zbyšek Pavelek,2,3 Blanka Klímová5 1Department of Psychiatry, Charles University in Prague, Prague, Czech Republic; 2Faculty of Medicine in Hradec Kralove and University...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/871f4a56e4234c20b13f2d378ce26512 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:871f4a56e4234c20b13f2d378ce26512 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:871f4a56e4234c20b13f2d378ce265122021-12-02T01:21:39ZTreatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review1178-2021https://doaj.org/article/871f4a56e4234c20b13f2d378ce265122018-05-01T00:00:00Zhttps://www.dovepress.com/treatment-of-behavioral-and-psychological-symptoms-of-dementias-with-p-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Jiří Masopust,1–4 Dita Protopopová,4 Martin Vališ,2,3 Zbyšek Pavelek,2,3 Blanka Klímová5 1Department of Psychiatry, Charles University in Prague, Prague, Czech Republic; 2Faculty of Medicine in Hradec Kralove and University Hospital, Hradec Kralove, Czech Republic; 3Department of Neurology, Charles University in Prague, Prague, Czech Republic; 4National Institute of Mental Health, Klecany, Czech Republic; 5Department of Applied Linguistics, University of Hradec Kralove, Hradec Kralove, Czech Republic Abstract: Behavioral and psychological symptoms represent common complications in patients with different types of dementia. Predominantly, they comprise psychosis, agitation and mood disorders, disinhibited behavior, impairment of the sleep and wakefulness rhythm, wandering, perseveration, pathological collecting, or shouting. Their appearance is related to more rapid progression of the disease, earlier institutionalization, use of physical restraints, and higher risk of mortality. Consequently, appearance of behavioral and psychological symptoms of dementia leads to higher costs of care provided and greater distress for caregivers. Clinical guidelines recommend nonpharmacological approaches as the first choice in the treatment of behavioral and psychological symptoms. Pharmacological therapy should be initiated only if the symptoms were not the result of somatic causes, did not respond to nonpharmacological interventions, or were not caused by the prior medication. Acetylcholinesterase inhibitors, memantine, antipsychotic drugs, antidepressants, mood stabilizers, and benzodiazepines are used. This review summarizes the current findings about the efficacy and safety of the treatment of the neuropsychiatric symptoms in dementias with psychopharmaceuticals. Recommendations for treatment with antipsychotics for this indication are described in detail as this drug group is prescribed most often and, at the same time, is related to the highest risk of adverse effects and increased mortality. Keywords: dementia, behavioral and psychological symptoms, treatment, psychopharmaceuticals, adverse effectsMasopust JProtopopová DVališ MPavelek ZKlímová BDove Medical Pressarticledementiabehavioral and psychological symptomstreatmentpsychopharmaceuticalsadverse effects.Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1211-1220 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
dementia behavioral and psychological symptoms treatment psychopharmaceuticals adverse effects. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
dementia behavioral and psychological symptoms treatment psychopharmaceuticals adverse effects. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Masopust J Protopopová D Vališ M Pavelek Z Klímová B Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| description |
Jiří Masopust,1–4 Dita Protopopová,4 Martin Vališ,2,3 Zbyšek Pavelek,2,3 Blanka Klímová5 1Department of Psychiatry, Charles University in Prague, Prague, Czech Republic; 2Faculty of Medicine in Hradec Kralove and University Hospital, Hradec Kralove, Czech Republic; 3Department of Neurology, Charles University in Prague, Prague, Czech Republic; 4National Institute of Mental Health, Klecany, Czech Republic; 5Department of Applied Linguistics, University of Hradec Kralove, Hradec Kralove, Czech Republic Abstract: Behavioral and psychological symptoms represent common complications in patients with different types of dementia. Predominantly, they comprise psychosis, agitation and mood disorders, disinhibited behavior, impairment of the sleep and wakefulness rhythm, wandering, perseveration, pathological collecting, or shouting. Their appearance is related to more rapid progression of the disease, earlier institutionalization, use of physical restraints, and higher risk of mortality. Consequently, appearance of behavioral and psychological symptoms of dementia leads to higher costs of care provided and greater distress for caregivers. Clinical guidelines recommend nonpharmacological approaches as the first choice in the treatment of behavioral and psychological symptoms. Pharmacological therapy should be initiated only if the symptoms were not the result of somatic causes, did not respond to nonpharmacological interventions, or were not caused by the prior medication. Acetylcholinesterase inhibitors, memantine, antipsychotic drugs, antidepressants, mood stabilizers, and benzodiazepines are used. This review summarizes the current findings about the efficacy and safety of the treatment of the neuropsychiatric symptoms in dementias with psychopharmaceuticals. Recommendations for treatment with antipsychotics for this indication are described in detail as this drug group is prescribed most often and, at the same time, is related to the highest risk of adverse effects and increased mortality. Keywords: dementia, behavioral and psychological symptoms, treatment, psychopharmaceuticals, adverse effects |
| format |
article |
| author |
Masopust J Protopopová D Vališ M Pavelek Z Klímová B |
| author_facet |
Masopust J Protopopová D Vališ M Pavelek Z Klímová B |
| author_sort |
Masopust J |
| title |
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| title_short |
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| title_full |
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| title_fullStr |
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| title_full_unstemmed |
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| title_sort |
treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/871f4a56e4234c20b13f2d378ce26512 |
| work_keys_str_mv |
AT masopustj treatmentofbehavioralandpsychologicalsymptomsofdementiaswithpsychopharmaceuticalsareview AT protopopovad treatmentofbehavioralandpsychologicalsymptomsofdementiaswithpsychopharmaceuticalsareview AT valism treatmentofbehavioralandpsychologicalsymptomsofdementiaswithpsychopharmaceuticalsareview AT pavelekz treatmentofbehavioralandpsychologicalsymptomsofdementiaswithpsychopharmaceuticalsareview AT klimovab treatmentofbehavioralandpsychologicalsymptomsofdementiaswithpsychopharmaceuticalsareview |
| _version_ |
1718403148112986112 |